What You Should Know:
– Method AI, a medical technology company focused on improving oncology outcomes secures $20M in Series A funding led by a private family office, with participation from Cleveland Clinic and JobsOhio Growth Capital Fund.
– The funds will be used to support the continued development of the company’s novel surgical ultrasound platform.
Optimizing Surgical Visualization
Method AI was founded in 2021 as a spin-off from Cleveland Clinic to solve surgical visualization challenges that were experienced by the clinic’s robotic surgeons. The company’s technology is designed to visualize anatomy that is deep below the surface of an organ, which is often beyond the view of current surgical camera systems. The platform will create a first-of-its-kind 3D subsurface map for physicians and provide them with real-time guidance based on an AI-generated surgical plan.
Method AI’s surgical navigation platform will allow for continuous 3D ultrasound imaging throughout a procedure. Its real-time algorithms will build a map of critical subsurface features and use machine learning to generate plans that guide physicians to the best possible surgical outcome. Method AI aims to significantly improve the cancer-free survival rate for patients and has the potential to reduce over $1Bin annual costs for the broader healthcare system.
“In complex oncology procedures, surgeons often have to remove tumors that are partially or completely embedded within the organ, making it extremely difficult to gauge the margins of the tumor during a live surgery,” said Doug Teany, Co-Founder and CEO of Method AI. “This incomplete view of the tumor and other critical anatomy leads to cancer left behind, unforeseen complications and loss of organ function. With the support of our investment partners, our technology can make the difference between completely removing a tumor or leaving part of it behind, which significantly impacts long-term patient outcomes.”
